Teva Seeks Startup Innovation for Pharma Challenges

Teva Pharmaceutical Industries has introduced Teva Rise, an open innovation platform aimed at accelerating the development of cutting-edge technologies. This initiative seeks to connect startups and tech companies with Teva's business units to address significant challenges within the pharmaceutical sector, including R&D, manufacturing, supply chain, and commercial operations.

The platform focuses on fostering innovation in areas such as artificial intelligence, digital health, advanced manufacturing, and biotechnology. Specific areas of interest include developing alternatives to animal models for drug development and utilizing AI to simulate clinical trial outcomes.

Teva intends to invest tens of millions of dollars into promising solutions identified through Teva Rise. This strategic move aims to strengthen the company's business, improve patient care through advanced treatments like smart devices for monitoring medication, and establish a competitive advantage in a rapidly evolving healthcare landscape.